(Q36365302)

13 August 2017

1 reference

title

Tissue angiotensin-converting enzyme inhibitors: are they more effective than serum angiotensin-converting enzyme inhibitors? (English)

1 reference

13 August 2017

Apurva D Shah

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6654115&resulttype=core&format=json

15 May 2020

Rohit R Arora

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6654115&resulttype=core&format=json

15 May 2020

publication date

1 December 2005

1 reference

13 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6654115&resulttype=core&format=json

15 May 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6654115&resulttype=core&format=json

15 May 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6654115&resulttype=core&format=json

15 May 2020

page(s)

551-555

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6654115&resulttype=core&format=json

Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function

15 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960281203

Physiology and pathophysiology of the adipose tissue renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960281203

Trandolapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960281203

Choosing the right ACE inhibitor. A guide to selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960281203

Mortality rates in elderly patients who take different angiotensin-converting enzyme inhibitors after acute myocardial infarction: a class effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960281203

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

12 December 2020

Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase

1 reference

12 December 2020

The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function

1 reference

12 December 2020

Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research

1 reference

12 December 2020

Angiotensin subtype-2 receptor (AT2 ) negatively regulates subtype-1 receptor (AT1 ) in signal transduction pathways in cultured porcine adrenal medullary chromaffin cells

1 reference

12 December 2020

A critical appraisal of the intrinsic pancreatic angiotensin-generating system

1 reference

12 December 2020

Signal transduction mechanisms of the angiotensin II type AT(1)-receptor: looking beyond the heterotrimeric G protein paradigm

1 reference

12 December 2020

Angiotensin mutant mice: a focus on the brain renin-angiotensin system.

1 reference

12 December 2020

Identification of two subtypes in the rat type I angiotensin II receptor

1 reference

12 December 2020

Angiotensin II type-1 receptor subtype cDNAs: differential tissue expression and hormonal regulation

1 reference

12 December 2020

Cloning, characterization, and expression of two angiotensin receptor (AT-1) isoforms from the mouse genome.

1 reference

12 December 2020

Inhibition of angiotensin converting enzyme by ramipril in serum and tissue of man

1 reference

12 December 2020

Angiotensin (A I, A II, A III) receptor characterization. Correlation of prostaglandin release with peptide degradation

1 reference

12 December 2020

Antihypertensive action of the converting enzyme inhibitor perindopril (S9490-3) in spontaneously hypertensive rats: comparison with enalapril (MK421) and ramipril (Hoe498).

1 reference

12 December 2020

Neovascularization produced by angiotensin II

1 reference

12 December 2020

Persistent tissue converting enzyme inhibition following chronic treatment with Hoe498 and MK421 in spontaneously hypertensive rats

1 reference

12 December 2020

Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat

1 reference

12 December 2020

Circulating and tissue angiotensin systems

1 reference

12 December 2020

Converting-enzyme inhibitors in the treatment of hypertension

1 reference

12 December 2020

Tissue distribution of rat angiotensinogen mRNA and structural analysis of its heterogeneity

1 reference

12 December 2020

Metabolism and blood levels of angiotensin II in normal subjects, renal disease, and essential hypertension

1 reference

12 December 2020

Regulation by angiotensin II of its receptors in resistance blood vessels

1 reference

12 December 2020

The chymase-angiotensin system in humans: biochemistry, molecular biology and potential role in cardiovascular diseases

1 reference

12 December 2020

Regulation of blood pressure by the type 1A angiotensin II receptor gene

1 reference

12 December 2020

Differential expression of angiotensin receptor 1A and 1B in mouse

1 reference

12 December 2020

Novel subtype of human angiotensin II type 1 receptor: cDNA cloning and expression

1 reference

12 December 2020

Cardiac angiotensin II formation: the angiotensin-I converting enzyme and human chymase.

1 reference

12 December 2020

Angiotensin II receptors and angiotensin II receptor antagonists.

1 reference

12 December 2020

Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study

1 reference

12 December 2020

Targeting deletion of angiotensin type 1B receptor gene in the mouse

1 reference

12 December 2020

Intrarenal production of angiotensin II.

1 reference

12 December 2020

Pharmacologic, pharmacokinetic, and therapeutic differences among ACE inhibitors

1 reference

12 December 2020

Mechanisms of cardiovascular risk reduction with ramipril: insights from HOPE and HOPE substudies

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960281203

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/CLC.4960281203

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6654115&resulttype=core&format=json

15 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6654115&resulttype=core&format=json

15 May 2020

16405197

1 reference